FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gary Martin

Research Profile

Chemicals & Drugs

Concepts & Ideas

Occupations

Devices

Procedures

Physiology

Skin Absorption

Objects

Microspheres

Co-author Network

Publications

TOP 3
Sara Jaffari; Gary P Martin; David J Barlow; Elizabeth Collins; Ben Forbes; Darragh Murnane
Rapid characterisation of the inherent dispersibility of respirable powders using dry dispersion laser diffraction.
F Benaouda; Marc B Brown; Gary P Martin; B Shah; Stuart A Jones
The influence of self-assembling supramolecular structures on the passive membrane transport of ion-paired molecules.
F Benaouda; M B Brown; Gary P Martin; S A Jones
Triggered in situ drug supersaturation and hydrophilic matrix self-assembly.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gary Martin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sara Jaffari; Gary P Martin; David J Barlow; Elizabeth Collins; Ben Forbes; Darragh Murnane
Rapid characterisation of the inherent dispersibility of respirable powders using dry dispersion laser diffraction.
International journal of pharmaceutics 2013;447(1-2):124-31.
2012: F Benaouda; Marc B Brown; Gary P Martin; B Shah; Stuart A Jones
The influence of self-assembling supramolecular structures on the passive membrane transport of ion-paired molecules.
International journal of pharmaceutics 2012;439(1-2):334-41.
2012: F Benaouda; M B Brown; Gary P Martin; S A Jones
Triggered in situ drug supersaturation and hydrophilic matrix self-assembly.
Pharmaceutical research 2012;29(12):3434-42.
2012: F Benaouda; M B Brown; S Ganguly; Stuart A Jones; Gary P Martin
Discriminating the molecular identity and function of discrete supramolecular structures in topical pharmaceutical formulations.
Molecular pharmaceutics 2012;9(9):2505-12.
2012: Waseem Kaialy; Hassan Larhrib; Gary P Martin; Ali Nokhodchi
The effect of engineered mannitol-lactose mixture on dry powder inhaler performance.
Pharmaceutical research 2012;29(8):2139-56.
2012: C I Grainger; Stuart A Jones; Gary P Martin; L L Merolla; M Saunders; R Telford; F Buttini; B Forbes
Critical characteristics for corticosteroid solution metered dose inhaler bioequivalence.
Molecular pharmaceutics 2012;9(3):563-9.
2012: Rim Jawad; Gary P Martin; Alex F Drake; Carole Elleman; Louic Vermeer; Brendon Woodhead; Paul G Royall
The measurement of the β/α anomer composition within amorphous lactose prepared by spray and freeze drying using a simple (1)H-NMR method.
Pharmaceutical research 2012;29(2):511-24.
2012: Waseem Kaialy; Ewa Kolosionek; Hassan Larhrib; Gary P Martin; Martyn D Ticehurst; Ali Nokhodchi
The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.
Colloids and surfaces. B, Biointerfaces 2012;89():29-39.
2011: Mohammed Taki; Xian-Ming Zeng; Sarah Ahmed; Christopher Marriott; Gary P Martin
The 'stage-by-stage' deposition of drugs from commercial single-active and combination dry powder inhaler formulations.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2011;43(4):225-35.
2011: Lamia Heikal; Gary P Martin; Manasi Nandi; Philip I Aaronson; Albert Ferro; Lea Ann Dailey
S-nitrosophytochelatins: investigation of the bioactivity of an oligopeptide nitric oxide delivery system.
Biomacromolecules 2011;12(6):2103-13.
2011: Mohammed Taki; Christopher Marriott; Xian-Ming Zeng; Gary P Martin
The production of 'aerodynamically equivalent' drug and excipient inhalable powders using a novel fractionation technique.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2011;77(2):283-96.
2010: Mustafa A Zaman; Gary P Martin; Gareth D Rees
Bioadhesion and retention of non-aqueous delivery systems in a dental hard tissue model.
Journal of dentistry 2010;38(9):757-64.
2010: Mohammed Taki; Christopher Marriott; Xian-Ming Zeng; Gary P Martin
Aerodynamic deposition of combination dry powder inhaler formulations in vitro: a comparison of three impactors.
International journal of pharmaceutics 2010;388(1-2):40-51.
2009: K Pangsomboon; S Bansal; Gary P Martin; P Suntinanalert; Sanae Kaewnopparat; Teerapol Srichana
Further characterization of a bacteriocin produced by Lactobacillus paracasei HL32.
Journal of applied microbiology 2009;106(6):1928-40.
2009: Lamia Heikal; Gary P Martin; Lea Ann Dailey
Characterisation of the decomposition behaviour of S-nitrosoglutathione and a new class of analogues: S-Nitrosophytochelatins.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2009;20(3):157-65.
2009: Akomeah Franklin ; Gary P Martin; Marc B Brown
Short-term iontophoretic and post-iontophoretic transport of model penetrants across excised human epidermis.
International journal of pharmaceutics 2009;367(1-2):162-8.
2009: C I Grainger; Leona L Greenwell; Gary P Martin; Ben Forbes
The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2009;71(2):318-24.
2009: Darragh Murnane; Gary P Martin; Christopher Marriott
Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals.
Journal of pharmaceutical sciences 2009;98(2):503-15.
2008: Darragh Murnane; Gary P Martin; Christopher Marriott
Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.
Pharmaceutical research 2008;25(10):2283-91.
2008: Darragh Murnane; Christopher Marriott; Gary P Martin
Polymorphic control of inhalation microparticles prepared by crystallization.
International journal of pharmaceutics 2008;361(1-2):141-9.
2008: M J Traynor; Marc B Brown; A Pannala; P Beck; Gary P Martin
Influence of alcohol on the release of tramadol from 24-h controlled-release formulations during in vitro dissolution experiments.
Drug development and industrial pharmacy 2008;34(8):885-9.
2008: Mustafa A Zaman; Gary P Martin; Gareth D Rees
Mucoadhesion, hydration and rheological properties of non-aqueous delivery systems (NADS) for the oral cavity.
Journal of dentistry 2008;36(5):351-9.
2008: Darragh Murnane; Christopher Marriott; Gary P Martin
Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;69(1):72-82.
2008: Darragh Murnane; Christopher Marriott; Gary P Martin
Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;69(1):94-105.
2008: Akomeah Franklin ; Gary P Martin; Andy G Muddle; Marc B Brown
Effect of abrasion induced by a rotating brush on the skin permeation of solutes with varying physicochemical properties.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;68(3):724-34.
2008: Chutima Jantarat; Naruedom Tangthong; Sarunyoo Songkro; Gary P Martin; Roongnapa Suedee
S-propranolol imprinted polymer nanoparticle-on-microsphere composite porous cellulose membrane for the enantioselectively controlled delivery of racemic propranolol.
International journal of pharmaceutics 2008;349(1-2):212-25.
2008: Marc B Brown; Matthew J Traynor; Gary P Martin; Akomeah Franklin
Transdermal drug delivery systems: skin perturbation devices.
Methods in molecular biology (Clifton, N.J.) 2008;437():119-39.
2007: Ana Grenha; Christopher I Grainger; Lea Ann Dailey; Begoña Seijo; Gary P Martin; Carmen Remuñán-López; Ben Forbes
Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;31(2):73-84.
2007: Akomeah Franklin ; Gary P Martin; Marc B Brown
Variability in human skin permeability in vitro: comparing penetrants with different physicochemical properties.
Journal of pharmaceutical sciences 2007;96(4):824-34.
2007: Xian-Ming Zeng; Helen B MacRitchie; Christopher Marriott; Gary P Martin
Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
International journal of pharmaceutics 2007;333(1-2):45-55.
2007: Gary P Martin; Christopher Marriott; Xian-Ming Zeng
Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.
Pharmaceutical research 2007;24(2):361-9.
2006: Christopher Marriott; Helen B MacRitchie; Xian-Ming Zeng; Gary P Martin
Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
International journal of pharmaceutics 2006;326(1-2):39-49.
2006: Stuart A Jones; Gary P Martin; Marc B Brown
Stabilisation of deoxyribonuclease in hydrofluoroalkanes using miscible vinyl polymers.
Journal of controlled release : official journal of the Controlled Release Society 2006;115(1):1-8.
2006: Xian-Ming Zeng; Helen B MacRitchie; Christopher Marriott; Gary P Martin
Correlation between inertial impaction and laser diffraction sizing data for aerosolized carrier-based dry powder formulations.
Pharmaceutical research 2006;23(9):2200-9.
2006: Gary P Martin; Helen B MacRitchie; Christopher Marriott; Xian-Ming Zeng
Characterisation of a carrier-free dry powder aerosol formulation using inertial impaction and laser diffraction.
Pharmaceutical research 2006;23(9):2210-9.
2006: Christopher I Grainger; Leona L Greenwell; David J Lockley; Gary P Martin; Ben Forbes
Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier.
Pharmaceutical research 2006;23(7):1482-90.
2006: Chatchada Bodhibukkana; Teerapol Srichana; Sanae Kaewnopparat; Naruedom Tangthong; Pisit Bouking; Gary P Martin; Roongnapa Suedee
Composite membrane of bacterially-derived cellulose and molecularly imprinted polymer for use as a transdermal enantioselective controlled-release system of racemic propranolol.
Journal of controlled release : official journal of the Controlled Release Society 2006;113(1):43-56.
2006: Roongnapa Suedee; Vatcharee Seechamnanturakit; Bhutorn Canyuk; Chitchamai Ovatlarnporn; Gary P Martin
Temperature sensitive dopamine-imprinted (N,N-methylene-bis-acrylamide cross-linked) polymer and its potential application to the selective extraction of adrenergic drugs from urine.
Journal of chromatography. A 2006;1114(2):239-49.
2006: Marc B Brown; Gary P Martin; Stuart A Jones; Akomeah Franklin
Dermal and transdermal drug delivery systems: current and future prospects.
Drug delivery 2006;13(3):175-87.
2006: Stuart A Jones; Gary P Martin; Marc B Brown
Manipulation of beclomethasone-hydrofluoroalkane interactions using biocompatible macromolecules.
Journal of pharmaceutical sciences 2006;95(5):1060-74.
2006: D Murnane; Gary P Martin; Christopher Marriott
Validation of a reverse-phase high performance liquid chromatographic method for concurrent assay of a weak base (salmeterol xinafoate) and a pharmacologically active steroid (fluticasone propionate).
Journal of pharmaceutical and biomedical analysis 2006;40(5):1149-54.
2005: Yong-Hong Liao; Marc B Brown; Stuart A Jones; Tahir Nazir; Gary P Martin
The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.
International journal of pharmaceutics 2005;304(1-2):29-39.
2005: Yong-Hong Liao; Stuart A Jones; Ben Forbes; Gary P Martin; Marc B Brown
Hyaluronan: pharmaceutical characterization and drug delivery.
Drug delivery 2005;12(6):327-42.
2005: Stuart A Jones; Gary P Martin; Marc B Brown
High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
International journal of pharmaceutics 2005;302(1-2):154-65.
2004: Yong-Hong Liao; Marc B Brown; Gary P Martin
Investigation of the stabilisation of freeze-dried lysozyme and the physical properties of the formulations.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(1):15-24.
2004: Stuart A Jones; Gary P Martin; Marc B Brown
Determination of polyvinylpyrrolidone using high-performance liquid chromatography.
Journal of pharmaceutical and biomedical analysis 2004;35(3):621-4.
2004: Akomeah Franklin ; Tahir Nazir; Gary P Martin; Marc B Brown
Effect of heat on the percutaneous absorption and skin retention of three model penetrants.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2004;21(2-3):337-45.
2004: Barbara T S Yff; Paul G Royall; Marc B Brown; Gary P Martin
An investigation of calibration methods for solution calorimetry.
International journal of pharmaceutics 2004;269(2):361-72.
2003: Yong-Hong Liao; Marc B Brown; Abdul Quader; Gary P Martin
Investigation of the physical properties of spray-dried stabilised lysozyme particles.
The Journal of pharmacy and pharmacology 2003;55(9):1213-21.
2003: Hassan Larhrib; Gary P Martin; David Prime; Christopher Marriott
Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2003;19(4):211-21.
2003: Hassan Larhrib; Gary P Martin; Christopher Marriott; David Prime
The influence of carrier and drug morphology on drug delivery from dry powder formulations.
International journal of pharmaceutics 2003;257(1-2):283-96.
2003: Ben Forbes; Atiya Shah; Gary P Martin; Alison B Lansley
The human bronchial epithelial cell line 16HBE14o- as a model system of the airways for studying drug transport.
International journal of pharmaceutics 2003;257(1-2):161-7.
2002: Yong-Hong Liao; Marc B Brown; Abdul Quader; Gary P Martin
Protective mechanism of stabilizing excipients against dehydration in the freeze-drying of proteins.
Pharmaceutical research 2002;19(12):1854-61.
2002: Yong-Hong Liao; Marc B Brown; Tahir Nazir; Abdul Quader; Gary P Martin
Effects of sucrose and trehalose on the preservation of the native structure of spray-dried lysozyme.
Pharmaceutical research 2002;19(12):1847-53.
2002: Roongnapa Suedee; Teerapol Srichana; R Chotivatesin; Gary P Martin
Stereoselective release behaviors of imprinted bead matrices.
Drug development and industrial pharmacy 2002;28(5):545-54.
2002: S T Lim; Ben Forbes; D J Berry; Gary P Martin; Marc B Brown
In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits.
International journal of pharmaceutics 2002;231(1):73-82.
2001: Xian-Ming Zeng; Gary P Martin; Christopher Marriott; J Pritchard
Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery.
Journal of pharmaceutical sciences 2001;90(9):1424-34.
2001: Marc B Brown; M Hanpanitcharoen; Gary P Martin
An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs.
International journal of pharmaceutics 2001;225(1-2):113-21.
2001: Xian-Ming Zeng; Gary P Martin; Christopher Marriott
Effects of molecular weight of polyvinylpyrrolidone on the glass transition and crystallization of co-lyophilized sucrose.
International journal of pharmaceutics 2001;218(1-2):63-73.
2001: Yong-Hong Liao; Marc B Brown; Gary P Martin
Turbidimetric and HPLC assays for the determination of formulated lysozyme activity.
The Journal of pharmacy and pharmacology 2001;53(4):549-54.
2001: S Amr; M B Brown; Gary P Martin; B Forbes
Activation of clindamycin phosphate by human skin.
Journal of applied microbiology 2001;90(4):550-4.
2001: S T Lim; B Forbes; Gary P Martin; M B Brown
In vivo and in vitro characterization of novel microparticulates based on hyaluronan and chitosan hydroglutamate.
AAPS PharmSciTech 2001;2(4):20.
2001: Gary P Martin; Christopher Marriott; J Pritchard
The use of lactose recrystallised from carbopol gels as a carrier for aerosolised salbutamol sulphate.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2001;51(1):55-62.
2000: S K Tee; Christopher Marriott; Xian-Ming Zeng; Gary P Martin
The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate.
International journal of pharmaceutics 2000;208(1-2):111-23.
2000: Xian-Ming Zeng; Gary P Martin; Christopher Marriott; J Pritchard
The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates.
The Journal of pharmacy and pharmacology 2000;52(10):1211-21.
2000: L A Gould; Alison B Lansley; Marc B Brown; Ben Forbes; Gary P Martin
Mitigation of surfactant erythrocyte toxicity by egg phosphatidylcholine.
The Journal of pharmacy and pharmacology 2000;52(10):1203-9.
2000: Xian-Ming Zeng; Gary P Martin; Christopher Marriott; J Pritchard
Crystallization of lactose from carbopol gels.
Pharmaceutical research 2000;17(7):879-86.
2000: Teerapol Srichana; Gary P Martin; Christopher Marriott
A human oral-throat cast integrated with a twin-stage impinger for evaluation of dry powder inhalers.
The Journal of pharmacy and pharmacology 2000;52(7):771-8.
2000: Xian-Ming Zeng; Gary P Martin; Christopher Marriott; J Pritchard
The influence of crystallization conditions on the morphology of lactose intended for use as a carrier for dry powder aerosols.
The Journal of pharmacy and pharmacology 2000;52(6):633-43.
2000: S T Lim; Gary P Martin; D J Berry; Marc B Brown
Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan.
Journal of controlled release : official journal of the Controlled Release Society 2000;66(2-3):281-92.
2000: Roongnapa Suedee; Teerapol Srichana; Gary P Martin
Evaluation of matrices containing molecularly imprinted polymers in the enantioselective-controlled delivery of beta-blockers.
Journal of controlled release : official journal of the Controlled Release Society 2000;66(2-3):135-47.
2000: S H Soozandehfar; J L Bragger; Gary P Martin; Andrew W Lloyd
Synthesis and bacterial degradation of an azopolymer.
International journal of pharmaceutics 2000;198(1):71-82.
2000: Xian-Ming Zeng; K H Pandhal; Gary P Martin
The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols.
International journal of pharmaceutics 2000;197(1-2):41-52.
2000: A B MacAdam; Z B Shafi; Christopher Marriott; Gary P Martin; S L James
Anti-mucus polyclonal antibody production, purification and linkage to the surface of albumin microspheres.
International journal of pharmaceutics 2000;195(1-2):147-58.
2000: Teerapol Srichana; A Brain; Christopher Marriott; Gary P Martin
A study of drug-carrier interactions in dry powder inhaler formulations using the Andersen cascade impactor, X-ray microanalysis and time of flight aerosol beam spectrometry (TOFABS).
Chemical & pharmaceutical bulletin 2000;48(2):167-74.
2000: Ben Forbes; N Hashmi; Gary P Martin; Alison B Lansley
Formulation of inhaled medicines: effect of delivery vehicle on immortalized epithelial cells.
Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 2000;13(3):281-8.
2000: Gary P Martin; D Ladenheim; Christopher Marriott; D A Hollingsbee; Marc B Brown
The influence of hydrocolloid patch composition on the bioavailability of triamcinolone acetonide in humans.
Drug development and industrial pharmacy 2000;26(1):35-43.
1999: Hassan Larhrib; Xian-Ming Zeng; Gary P Martin; Christopher Marriott; J Pritchard
The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate.
International journal of pharmaceutics 1999;191(1):1-14.
1999: Xian-Ming Zeng; Gary P Martin; S K Tee; A A Ghoush; Christopher Marriott
Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation.
International journal of pharmaceutics 1999;182(2):133-44.
1998: Teerapol Srichana; Gary P Martin; Christopher Marriott
Dry powder inhalers: the influence of device resistance and powder formulation on drug and lactose deposition in vitro.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1998;7(1):73-80.
1996: D Ladenheim; Gary P Martin; Christopher Marriott; D A Hollingsbee; M B Brown
An in-vitro study of the effect of hydrocolloid patch occlusion on the penetration of triamcinolone acetonide through skin in man.
The Journal of pharmacy and pharmacology 1996;48(8):806-11.
1995: M B Brown; Christopher Marriott; Gary P Martin
The effect of hyaluronan on the in vitro deposition of diclofenac within the skin.
International journal of tissue reactions 1995;17(4):133-40.
1994: J Bilbruck; Geoffrey W Hanlon; Paul R Gard; Gary P Martin
The effects of transcervical monofilament insertion on the microbial status of the uterus in guinea-pigs.
The Journal of pharmacy and pharmacology 1994;46(3):213-6.
1994: M Haghpanah; Christopher Marriott; Gary P Martin
Potential use of microencapsulation for sustained drug delivery to the respiratory tract.
Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 1994;7(2):185-8.
1993: A Graham; A Hasani; Eric W F W Alton; Gary P Martin; Christopher Marriott; M E Hodson; S W Clarke; Duncan M Geddes
No added benefit from nebulized amiloride in patients with cystic fibrosis.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1993;6(9):1243-8.
1993: Gary P Martin; B E Loveday; Christopher Marriott
Bromhexine plus oxytetracycline: the effect of combined administration upon the rheological properties of mucus from the mini-pig.
The Journal of pharmacy and pharmacology 1993;45(2):126-30.
1992: L M el-Hariri; Christopher Marriott; Gary P Martin
The mitigating effects of phosphatidylcholines on bile salt- and lysophosphatidylcholine-induced membrane damage.
The Journal of pharmacy and pharmacology 1992;44(8):651-4.
1992: Gary P Martin; L M el-Hariri; Christopher Marriott
Bile salt- and lysophosphatidylcholine-induced membrane damage in human erythrocytes.
The Journal of pharmacy and pharmacology 1992;44(8):646-50.
1991: A H Batts; Christopher Marriott; Gary P Martin; S W Bond; J L Greaves; Clive G Wilson
The use of a radiolabelled saccharin solution to monitor the effect of the preservatives thiomersal, benzalkonium chloride and EDTA on human nasal clearance.
The Journal of pharmacy and pharmacology 1991;43(3):180-5.
1990: Gary P Martin; B E Loveday; Christopher Marriott
The effect of bromhexine hydrochloride on the viscoelastic properties of mucus from the mini-pig.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1990;3(4):392-6.
1990: A H Batts; Christopher Marriott; Gary P Martin; C F Wood; S W Bond
The effect of some preservatives used in nasal preparations on the mucus and ciliary components of mucociliary clearance.
The Journal of pharmacy and pharmacology 1990;42(3):145-51.
1989: A H Batts; Christopher Marriott; Gary P Martin; S W Bond
The effect of some preservatives used in nasal preparations on mucociliary clearance.
The Journal of pharmacy and pharmacology 1989;41(3):156-9.
1989: K M Wilkins; Geoffrey W Hanlon; Gary P Martin; Christopher Marriott
The migration of bacteria through gels in the presence of IUCD monofilament tails.
Contraception 1989;39(2):205-16.
1988: M Jacobs; Gary P Martin; Christopher Marriott
Effects of phosphatidylcholine on the topical bioavailability of corticosteroids assessed by the human skin blanching assay.
The Journal of pharmacy and pharmacology 1988;40(12):829-33.
1985: N C Turner; Gary P Martin; Christopher Marriott
The influence of native porcine gastric mucus gel on hydrogen ion diffusion: the effect of potentially ulcerogenic agents.
The Journal of pharmacy and pharmacology 1985;37(11):776-80.
1985: Gary P Martin; R S Newbery; N C Turner; C Marriott
Gastric mucosal injury by bile acids: the influence of phospholipids.
Gastroentérologie clinique et biologique 1985;9(12 Pt 2):80-3.
1981: Gary P Martin; Christopher Marriott
Membrane damage by bile salts: the protective function of phospholipids.
The Journal of pharmacy and pharmacology 1981;33(12):754-9.
1981: Gary P Martin; Christopher Marriott; I W Kellaway
The interaction of progesterone with mucus glycoproteins.
Pharmaceutica acta Helvetiae 1981;56(1):5-8.